Q4 performance declined year-on-year, Imeik Technology Development continues to increase investment in research and development | Interpretations

① In 2024, Imeik Technology Development's revenue and Net income growth rates both fell to single digits, and in Q4, there was even a decline in performance. ② The company continues to increase its investment in research and development, with products like injectable botulinum toxin type A entering the registration application stage.

cls.cnMar 19 11:03 ET

The performance in the first year of the bet was thrilling without danger. "The first stock for allergen detection on the Star" Haobor's pressure is beginning to show.

①In 2024, Haobor "barely" achieved its first year's betting target after deducting specific Business; ②2024 marks the first time in seven years that the company's Net income falls below 40 million yuan, and it is also the lowest since landing on the Star.

cls.cnMar 18 00:20 ET

A large number of consultations! The benefits of childcare subsidies continue to be released, and Assisted Reproduction companies are looking forward to a "combination punch."

① Recently, policies favorable for child-rearing have emerged from both central and local governments, with some regions even offering substantial monetary incentives to encourage childbirth. ② Industry experts pointed out to reporters at Caijing that the introduction of child-rearing subsidy policies can, to some extent, reduce the burden and concerns for young couples regarding childbirth. ③ Insiders from Assisted Reproduction companies have expressed that measures such as promoting cultural awareness of male responsibility in child-rearing are also highly anticipated in the industry.

cls.cnMar 17 01:44 ET

The display chip industry is approaching a cyclical turning point, and the anticipated synergy from leading consolidation is promising.

① The display chip Industry is experiencing a recovery this year. Recently, Xinxiang Micro announced its acquisition of Aixiasheng, which is expected to be a key signal for the industry to reach a turning point; ② Both companies focus on the display chip field, and the integration effect after the company restructuring is significant; ③ Peking Electronic Control is an important Shareholder of Xinxiang Micro, and in its "chip-screen" ecosystem, the synergistic effects between Xinxiang Micro and related parties such as Yandong Micro and JD.com will also be stimulated, becoming an important driving force for the industry's recovery.

cls.cnMar 16 20:38 ET

Dramatic scene! Shanghai Kinetic Medical is being sued by the chairman's own company, escalating the equity repurchase dispute to judicial contention.

① Shanghai Xinchengyi, controlled by Yuan Zheng, has sued Shanghai Kinetic Medical, chaired by Yuan Zheng, requesting the annulment of the previous Board of Directors resolution; ② Lawyers believe that share buyback is a significant matter for the company, directly affecting the interests of small and medium shareholders, and this lawsuit also sends a signal of corporate governance risk to the market; ③ In the current predicament of Shanghai Kinetic Medical, the protection of small and medium investors' interests is urgent and it is necessary to ensure that the opinions of all shareholders are treated fairly.

cls.cnMar 14 11:58 ET

0.124 billion USD! FOSUN PHARMA and United Family Healthcare "completely part ways" | Quick announcement.

① FOSUN PHARMA's subsidiary plans to sell a 6.6% stake in the symbol company for 0.124 billion USD; ② The relationship between FOSUN PHARMA and Huameijia can be traced back to 2009; ③ After this Trade is completed, FOSUN PHARMA will completely exit Huameijia.

cls.cnMar 13 11:26 ET